This review examines the existing knowledge about Ru (II)/(III) ion complexes with a
potential application in medicine or pharmacy, which may offer greater potential in cancer …

The synergistic action of light, oxygen and a photosensitizer (PS) has found applications for
decades in medicine under the name of photodynamic therapy (PDT) for the treatment of …

More than 10 million death tolls in 2020 were reported as a result of heinous impact of
cancer, making it second most prime cause of death after cardiovascular diseases. In …

Ruthenium (Ru) complexes are known for their promising anticancer activity presumably
due to octahedral coordination geometry, slow ligand exchange rate, the range of different …

Ru (II) polypyridyl complexes are of great interest for their unique biological, photophysical,
optical, catalytic and electronic properties. This class of complexes demonstrates a number …

The reaction of trans-[RuCl2 (PPh3) 3](Ph= C6H5) with 2-thio-1, 3-pyrimidine (HTPYM) and
6-thiopurines (TPs) produced mainly crystalline solids that consist of cis, cis, trans-[Ru …

Due to acquired resistance or limitations of the currently approved drugs against cancer,
there is an urgent need for the development of new classes of compounds. Among others …

Ru (II)-polypyridyl complexes are of increasing interest in photodynamic therapy (PDT) due
to their easily tunable photophysical and photochemical properties. However, short …

Ruthenium (II) and iridium (III) coordination compounds display excellent structural,
photophysical, and biological properties which make them highly promising as anticancer …

Two novel ruthenium (II) polypyridyl complexes, namely,[Ru (dmp) 2 (CAPIP)](ClO 4) 2 (Ru
(II)-1) and [Ru (dmp) 2 (CFPIP)](ClO 4) 2 (Ru (II)-2), which respectively contain (E)-2-(2 …